STOCK TITAN

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2023 after the close of the U.S. financial markets on Thursday, August 3, 2023. The company's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on August 3rd beginning at 4:30 p.m. Eastern time. Participants are encouraged to pre-register for the conference call. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. A webcast of the call can also be accessed at OPKO’s Investor Relations page. A telephone replay and webcast replay will be available after the completion of the live conference call.
Positive
  • None.
Negative
  • None.

MIAMI, July 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2023 after the close of the U.S. financial markets on Thursday, August 3, 2023. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on August 3rd beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available until August 10, 2023 by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 7009686. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com

 


FAQ

What are OPKO Health, Inc.'s plans for reporting operating and financial results?

OPKO Health, Inc. plans to report operating and financial results for the three and six months ended June 30, 2023 after the close of the U.S. financial markets on Thursday, August 3, 2023.

When will the conference call and live audio webcast take place?

The conference call and live audio webcast will take place on August 3rd beginning at 4:30 p.m. Eastern time.

How can participants access the webcast of the call?

Participants can access the webcast of the call at OPKO’s Investor Relations page.

How long will the telephone replay be available?

The telephone replay will be available until August 10, 2023.

When will the webcast replay be available?

The webcast replay will be available beginning approximately one hour after the completion of the live conference call.

Opko Health Inc.

NASDAQ:OPK

OPK Rankings

OPK Latest News

OPK Stock Data

1.06B
682.48M
54.4%
28.06%
13.43%
Diagnostics & Research
Pharmaceutical Preparations
Link
United States of America
MIAMI